Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Impact Of Sacral Neuromodulation On Urine Markers For IC|
- The purpose of this study is measure urine biomarkers levels in patients with interstitial cystitis who have elected to undergo sacral nerve stimulation as a treatment modality for their disease. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Urines were collected and sent for urine marker analysis.
|Study Start Date:||February 2004|
|Study Completion Date:||December 2007|
|Primary Completion Date:||December 2006 (Final data collection date for primary outcome measure)|
One arm study. Urine collection.
Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.
|United States, Michigan|
|Beaumont Hospital - Royal Oak|
|Royal Oak, Michigan, United States, 48073|
|Principal Investigator:||Kenneth Peters, MD||William Beaumont Hospitals|